The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction

被引：2
|
作者：
Svilaas, T [1 ]
van der Horst, ICC [1 ]
Zijlstra, F [1 ]
机构：
[1] Univ Groningen, Med Ctr, Dept Cardiol, Ctr Thorax, NL-9700 RB Groningen, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷 / 23期
关键词：
D O I：
10.1093/eurheartj/ehi553
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2479 / 2481
页数：3
相关论文
共 50 条
  • [1] Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
    Tereshchenko, Andrey S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 918 - 927
  • [2] Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction
    Howard, J. P.
    Jones, D. A.
    Gallagher, S.
    Rathod, K.
    Antoniou, S.
    Wright, P.
    Knight, C.
    Mathur, A.
    Weerackody, R.
    Wragg, A.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Glycoprotein IIb/IIIa Inhibitors to Facilitate Percutaneous Intervention in ST-Elevation Myocardial Infarction - The Sooner not Necessarily the Better
    Guzman, Luis A.
    [J]. CIRCULATION JOURNAL, 2010, 74 (08) : 1528 - 1529
  • [4] Clinical Benefits of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Elevation Myocardial Infarction Pretreated with Clopidogrel before Primary Percutaneous Coronary Intervention
    Sim, Don Sun
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 33B - 33B
  • [5] Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction
    Holper, EM
    Giugliano, RP
    Antman, EM
    [J]. CORONARY ARTERY DISEASE, 1999, 10 (08) : 567 - 573
  • [6] Current role of glycoprotein IIb/IIIa receptor inhibitors in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention after pretreatment with loading dose thienopyridines
    Dong, Lili
    Wang, Yongshi
    Wu, Boting
    Shu, Xianhong
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) : 608 - 613
  • [7] A meta-analysis of the effectiveness and safety of glycoprotein IIb/IIIa inhibitors for primary percutaneous coronary intervention in unselected patients with st-segment elevation myocardial infarction
    Kouz, Remi
    Kouz, Simon
    Schampaert, Erick
    Rinfret, Stephane
    Eisenberg, Mark
    lauzon, ClauDe
    Nguyen, Michel
    Harvey, Richard
    Huynh, Than
    [J]. CIRCULATION, 2007, 116 (16) : 710 - 711
  • [8] The use of glycoprotein IIb/IIIa receptor blockers in primary percutaneous coronary intervention for ST-elevation myocardial infarction: results of the international Shakespeare Registry
    Gitt, AK
    Gottwik, MG
    Bassand, JP
    Seabra-Gomes, R
    Hasdai, D
    Fioretti, P
    Dawkins, K
    Senges, J
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 269 - 269
  • [9] Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction - A meta-analysis
    Montalescot, G
    Borentain, M
    Payot, L
    Collet, JP
    Thomas, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03): : 362 - 366
  • [10] Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on renal function in patients with ST-segment elevation myocardial infarction treated with primary or rescue percutaneous coronary intervention
    Osherov, Azriel B.
    Roguin, Ariel
    Aronson, Doron
    Grenadier, Ehud
    Kerner, Arthur
    Boulus, Monther
    Kapeliovich, Michael
    Hani, Amad
    Hammerman, Haim
    Beyar, Rafael
    Nikolsky, Eugenia
    [J]. EUROINTERVENTION, 2009, 5 (05) : 604 - 609
12345